Growth hormone therapy transiently increases apolipoprotein(a) in short beta-thalassaemia major children with normal growth hormone reserve.

doi:10.1016/s0021-9150(96)06001-7

Back to search

Article

Growth hormone therapy transiently increases apolipoprotein(a) in short beta-thalassaemia major children with normal growth hormone reserve.

Atherosclerosis - 10 Feb 1997

Tam S C, Pang R W, Janus E D, Kwan E Y, Low L C

Abstract excerpt

Recombinant human growth hormone (rhGH) is now available for treatment of short stature due to growth hormone (GH) deficiency. It's potential use in other causes of short stature raises concerns about adverse effects of long term treatment on carbohydrate and lipoprotein metabolism. We describe t...

Topics

Adolescent
Alleles
Apolipoproteins A
Body Height
Child
Female
Human Growth Hormone
Humans
Male
Phenotype
Recombinant Proteins
Reference Values
Time Factors
beta-Thalassemia

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.